immunotherapy

In the late 1960s, a group of scientists and volunteers at UCLA came together to develop a cancer center they hoped would become renowned for excellence in research, education and patient care. Today, UCLA Health’s Jonsson [...]

Researchers have developed a breakthrough in cancer treatment known as chimeric antigen receptor (CAR) T-cell therapy. This promising form of immunotherapy attacks cancerous cells in the body. In 2017, the U.S. Food and Drug Administration (FDA) approved the first CAR T-cell treatments for patients with specific types of leukemia and lymphoma.

What is CAR T-cell therapy?

Immunotherapy [...]

In 2015, ESPN reporter Holly Row was diagnosed with desmoplastic melanoma, a rare, fast-spreading form of skin cancer. After a first surgery, she enrolled in a UCLA clinical trial led by Dr. Antoni Ribas testing a new approach [...]

Medical researchers have had breakthroughs in treating certain types of cancer by bolstering a patient’s immune system. Known as immunotherapy, or biologic therapy, it treats cancer differently than established treatments such as chemotherapy, radiation, bone marrow transplant and surgery.

To date, the U.S. Food and [...]